Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
Oka M, Fukuda M, Nagashima S, Fukuda M, Kinoshita A, Soda H, Doi S, Narasaki F, Suenaga M, Takatani H, Nakamura Y, Kawabata S, Tsurutani J, Kanda T, Kohno S.
Oka M, et al.
Cancer Chemother Pharmacol. 2001 Dec;48(6):446-50. doi: 10.1007/s002800100369.
Cancer Chemother Pharmacol. 2001.
PMID: 11800024
Clinical Trial.